| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,475 |
3,475 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-05-12 |
4 |
D |
$59.30 |
$92,864 |
D/D |
(1,566) |
66,284 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2015-05-12 |
4 |
D |
$121.09 |
$189,627 |
D/D |
(1,566) |
82,080 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2010-10-29 |
4 |
A |
$13.23 |
$21,188 |
D/D |
1,602 |
32,602 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-04-29 |
4 |
A |
$13.23 |
$21,426 |
D/D |
1,620 |
24,455 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-05-16 |
4 |
S |
$56.86 |
$105,994 |
D/D |
(1,864) |
60,950 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2015-05-18 |
4 |
AS |
$124.78 |
$232,584 |
D/D |
(1,864) |
76,746 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2015-06-05 |
4 |
AS |
$122.32 |
$228,001 |
D/D |
(1,864) |
72,846 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-03-01 |
4 |
D |
$59.61 |
$113,736 |
D/D |
(1,908) |
44,589 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-06-04 |
4 |
D |
$92.07 |
$178,063 |
D/D |
(1,934) |
155,167 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2009-08-10 |
4 |
AS |
$19.85 |
$39,701 |
D/D |
(2,000) |
10,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2009-08-10 |
4 |
OE |
$2.76 |
$5,520 |
D/D |
2,000 |
12,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2009-09-10 |
4 |
OE |
$2.76 |
$5,520 |
D/D |
2,000 |
12,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2009-09-10 |
4 |
AS |
$19.31 |
$38,619 |
D/D |
(2,000) |
10,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2009-10-12 |
4 |
OE |
$2.76 |
$5,520 |
D/D |
2,000 |
12,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2009-10-12 |
4 |
AS |
$17.08 |
$34,159 |
D/D |
(2,000) |
10,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-04-12 |
4 |
OE |
$2.76 |
$5,520 |
D/D |
2,000 |
12,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-04-12 |
4 |
AS |
$23.24 |
$46,476 |
D/D |
(2,000) |
10,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-05-10 |
4 |
OE |
$2.76 |
$5,520 |
D/D |
2,000 |
12,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-05-10 |
4 |
AS |
$21.77 |
$43,541 |
D/D |
(2,000) |
10,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-06-10 |
4 |
OE |
$2.76 |
$5,520 |
D/D |
2,000 |
12,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-06-10 |
4 |
AS |
$20.98 |
$41,956 |
D/D |
(2,000) |
10,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-07-12 |
4 |
OE |
$2.76 |
$5,520 |
D/D |
2,000 |
12,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2010-07-12 |
4 |
AS |
$19.95 |
$39,898 |
D/D |
(2,000) |
10,416 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
294 Records found
|
|
Page 4 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
